3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
250
Lung Neoplasms
176
Small Cell Lung Carcinoma
37
Breast Neoplasms
37
Neoplasms
25
Neoplasm Metastasis
19
Adenocarcinoma of Lung
17
Ovarian Neoplasms
14
Mesothelioma, Malignant
14
Melanoma
13
Stomach Neoplasms
12
Mesothelioma
12
Brain Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
11
Colorectal Neoplasms
11
Prostatic Neoplasms
10
Esophageal Neoplasms
10
Pancreatic Neoplasms
9
Carcinoma, Renal Cell
9
Lung Diseases
7
Head and Neck Neoplasms
7
Colonic Neoplasms
7
Uterine Cervical Neoplasms
6
Urinary Bladder Neoplasms
6
Triple Negative Breast Neoplasms
5
Thymoma
5
Sarcoma
5
Pleural Effusion, Malignant
5
Carcinoma, Ovarian Epithelial
5
Carcinoma
5
Interventions
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Tertiary Lymphoid Structures
×
Thoracic
×
Clear all
NCT06084689
2025-09-02
EMPIRE
Institut Bergonié
Phase 2
Withdrawn